Risk factors for non-haemorrhagic stroke and the effect of lipid-modifying therapy.
Jackson
Peter R
PR
D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D012307:Risk Factors; D020521:Stroke / Q000209:etiology* / Q000517:prevention & control
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents